Isoliquiritigenin inhibits cell proliferation and migration through the PI3K/AKT signaling pathway in A549 lung cancer cells

about

Isoliquiritigenin inhibits cell proliferation and migration through the PI3K/AKT signaling pathway in A549 lung cancer cells

Item

http://www.wikidata.org/entity/Q57788685

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Isoliquiritigenin inhibits cel ...... hway in A549 lung cancer cells

@en

Isoliquiritigenin inhibits cel ...... hway in A549 lung cancer cells

@nl

type

Item

label

Isoliquiritigenin inhibits cel ...... hway in A549 lung cancer cells

@en

Isoliquiritigenin inhibits cel ...... hway in A549 lung cancer cells

@nl

prefLabel

Isoliquiritigenin inhibits cel ...... hway in A549 lung cancer cells

@en

Isoliquiritigenin inhibits cel ...... hway in A549 lung cancer cells

@nl

P1476

Isoliquiritigenin inhibits cel ...... hway in A549 lung cancer cells

@en

P2093

Haitao Liu

http://www.w3.org/2001/XMLSchema#string

Jianxin Wang

http://www.w3.org/2001/XMLSchema#string

Jinpeng Sun

http://www.w3.org/2001/XMLSchema#string

Tao Tian

http://www.w3.org/2001/XMLSchema#string

Yanchun Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics

Immunotherapy in the treatment of non-small cell lung cancer

The Protective Effects of Isoliquiritigenin and Glycyrrhetinic Acid against Triptolide-Induced Oxidative Stress in HepG2 Cells Involve Nrf2 Activation

Reprogramming induced by isoliquiritigenin diminishes melanoma cachexia through mTORC2-AKT-GSK3β signaling

MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin.

Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer.

Epidemiology, etiology, and prevention of lung cancer.

The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions.

Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.

Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition).

P304

6133-6139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.9344

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30344755

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6176347

http://www.w3.org/2001/XMLSchema#string